Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis
Ann Rheum Dis
.
2018 Feb;77(2):e6.
doi: 10.1136/annrheumdis-2017-211622.
Epub 2017 May 13.
Authors
Maxime Samson
1
2
,
Thibault Ghesquière
2
,
Sabine Berthier
1
,
Bernard Bonnotte
1
2
Affiliations
1
Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, Dijon, France.
2
INSERM, UMR1098, University of Bourgogne Franche-Comté, FHU INCREASE, Dijon, France.
PMID:
28501800
DOI:
10.1136/annrheumdis-2017-211622
No abstract available
Keywords:
Giant cell arteritis; Th1 cells; Th17 cells; Treg; ustekinumab.
Publication types
Letter
Comment
MeSH terms
Giant Cell Arteritis*
Humans
Polymyalgia Rheumatica
Th17 Cells
Ustekinumab*
Substances
Ustekinumab